Pfizer may work with BioNTech to develop coronavirus vaccine: R&D head

Topics Pfizer

Pfizer Inc is considering a collaboration with German drugmaker BioNTech to develop vaccines for the coronavirus using BioNTech's mRNA-based drug development platform, Pfizer's R&D head told Reuters on Thursday. Pfizer Chief Scientific Officer Mikael Dolsten was one of the pharmaceutical executives who attended a meeting with U.

S. President Donald Trump to discuss possible vaccines and treatments for the fast-spreading virus on Monday. He had said then that the company was working on developing an anti-viral therapy to help.....

This article is no longer available in our repository.

There could be multiple reasons for this.